APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 213 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $200,575,258 | -61.7% | 5,272,746 | -8.3% | 0.01% | -57.1% |
| Q2 2023 | $523,608,821 | +3.7% | 5,747,627 | -24.9% | 0.01% | -6.7% |
| Q1 2023 | $504,953,548 | +26.8% | 7,655,451 | -0.6% | 0.02% | +25.0% |
| Q4 2022 | $398,383,871 | -17.7% | 7,704,194 | +8.7% | 0.01% | -25.0% |
| Q3 2022 | $483,995,000 | +57.4% | 7,086,330 | +4.2% | 0.02% | +60.0% |
| Q2 2022 | $307,430,000 | +2.1% | 6,798,544 | +14.8% | 0.01% | +25.0% |
| Q1 2022 | $300,993,000 | +8.5% | 5,923,920 | +1.0% | 0.01% | +14.3% |
| Q4 2021 | $277,331,000 | +53.9% | 5,865,712 | +7.3% | 0.01% | +40.0% |
| Q3 2021 | $180,168,000 | -49.7% | 5,466,191 | -3.6% | 0.01% | -50.0% |
| Q2 2021 | $358,389,000 | +41.9% | 5,670,732 | -3.7% | 0.01% | +42.9% |
| Q1 2021 | $252,607,000 | -26.6% | 5,886,948 | -2.1% | 0.01% | -36.4% |
| Q4 2020 | $344,056,000 | +90.7% | 6,014,948 | +0.6% | 0.01% | +57.1% |
| Q3 2020 | $180,424,000 | -10.6% | 5,980,261 | -3.2% | 0.01% | -12.5% |
| Q2 2020 | $201,734,000 | +29.5% | 6,176,808 | +6.2% | 0.01% | 0.0% |
| Q1 2020 | $155,818,000 | +7.0% | 5,816,260 | +22.3% | 0.01% | +33.3% |
| Q4 2019 | $145,675,000 | +28.6% | 4,757,505 | +1.2% | 0.01% | +20.0% |
| Q3 2019 | $113,281,000 | -0.7% | 4,702,370 | +4.4% | 0.01% | 0.0% |
| Q2 2019 | $114,085,000 | +57.2% | 4,502,117 | +21.0% | 0.01% | +66.7% |
| Q1 2019 | $72,560,000 | +47.5% | 3,721,032 | -0.3% | 0.00% | +50.0% |
| Q4 2018 | $49,208,000 | -3.0% | 3,730,626 | +30.8% | 0.00% | 0.0% |
| Q3 2018 | $50,730,000 | -17.6% | 2,853,195 | +1.9% | 0.00% | -33.3% |
| Q2 2018 | $61,578,000 | +151.6% | 2,798,968 | +152.9% | 0.00% | +200.0% |
| Q1 2018 | $24,473,000 | +16.0% | 1,106,847 | +13.9% | 0.00% | 0.0% |
| Q4 2017 | $21,096,000 | – | 972,152 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |